Related Experiment Videos
Accordion-like prosthesis for modified Blalock-Taussig shunt
Antonio F Corno1, Michel Hurni, Piergiorgio Tozzi
1Department of Cardiovascular Surgery, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. antonio.corno@chuv.hospvd.ch
Asian Cardiovascular & Thoracic Annals
|September 30, 2003
Summary
This study found that a novel tubular prosthesis for the modified Blalock-Taussig shunt significantly reduced complications. The accordion-like shunt prosthesis proved safe and effective in pediatric patients undergoing cardiac surgery.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Biomedical Engineering
Background:
- Modified Blalock-Taussig shunt is a critical palliative procedure for cyanotic heart disease.
- Traditional shunts can lead to pulmonary artery distortion and other complications.
- Novel prostheses are needed to improve outcomes and reduce morbidity.
Purpose of the Study:
- To evaluate the safety and efficacy of a novel tubular accordion-like prosthesis for the modified Blalock-Taussig shunt.
- To assess early and late complications associated with this new shunt prosthesis.
- To compare outcomes with traditional shunt procedures.
Main Methods:
- Prospective study of 26 pediatric patients (mean age 17.9 months) undergoing modified Blalock-Taussig shunt with the tubular prosthesis.
- Mean follow-up of 10.9 months.
- Shunt patency assessed by Doppler echocardiography and angiography.
Main Results:
- One death occurred due to excessive pulmonary blood flow in a neonate with hypoplastic left heart syndrome.
- Three reoperations were needed for shunt-related issues (2 early, 1 late).
- No shunt obstruction, kinking, bleeding, infection, or serous fluid leakage occurred. Pulmonary artery reconstruction was not required.
Conclusions:
- The tubular accordion-like prosthesis is a safe and effective alternative for modified Blalock-Taussig shunt procedures.
- This prosthesis helps mitigate early and late complications, particularly pulmonary artery distortion.
- Further research may support its wider adoption in pediatric cardiac surgery.